These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25333998)

  • 1. Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.
    Liu Y; Wang X; Wang Y; Zhang Y; Zheng K; Yan H; Zhang L; Chen W; Wang X; Liu Q; Wang S; Wang Y
    Int J Oncol; 2015 Jan; 46(1):299-307. PubMed ID: 25333998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
    Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y
    Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNX-2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells.
    Wang SX; Ju HQ; Liu KS; Zhang JX; Wang X; Xiang YF; Wang R; Liu JY; Liu QY; Xia M; Xing GW; Liu Z; Wang YF
    Biosci Biotechnol Biochem; 2011; 75(8):1540-5. PubMed ID: 21821931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.
    Ui T; Morishima K; Saito S; Sakuma Y; Fujii H; Hosoya Y; Ishikawa S; Aburatani H; Fukayama M; Niki T; Yasuda Y
    Oncol Rep; 2014 Feb; 31(2):619-24. PubMed ID: 24317439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
    Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
    Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heat shock protein 90 inhibitor SNX-2112 inhibits B16 melanoma cell growth in vitro and in vivo.
    Liu KS; Ding WC; Wang SX; Liu Z; Xing GW; Wang Y; Wang YF
    Oncol Rep; 2012 Jun; 27(6):1904-10. PubMed ID: 22447251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of SNX-7081 and SNX-2112 on cell cycle, apoptosis and Hsp90 client proteins in human cancer cells.
    Wang X; Wang S; Liu Y; Huang D; Zheng K; Zhang Y; Wang X; Liu Q; Yang D; Wang Y
    Oncol Rep; 2015 Jan; 33(1):230-8. PubMed ID: 25334086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK.
    Okawa Y; Hideshima T; Steed P; Vallet S; Hall S; Huang K; Rice J; Barabasz A; Foley B; Ikeda H; Raje N; Kiziltepe T; Yasui H; Enatsu S; Anderson KC
    Blood; 2009 Jan; 113(4):846-55. PubMed ID: 18948577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor activity of the HSP90 inhibitor SNX-2112 in pediatric cancer cell lines.
    Chinn DC; Holland WS; Yoon JM; Zwerdling T; Mack PC
    Pediatr Blood Cancer; 2012 Jun; 58(6):885-90. PubMed ID: 21796766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer.
    Wang S; Du Z; Luo J; Wang X; Li H; Liu Y; Zhang Y; Ma J; Xiao W; Wang Y; Zhong X
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1405-16. PubMed ID: 25563492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel HDAC inhibitor OBP-801/YM753 enhances the effects of 5-fluorouracil with radiation on esophageal squamous carcinoma cells.
    Furutani A; Sowa Y; Fujiwara H; Otsuji E; Sakai T
    Oncol Res; 2014; 21(5):281-6. PubMed ID: 24854104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt.
    Lee HH; Ye S; Li XJ; Lee KB; Park MH; Kim SM
    Oncol Rep; 2014 Jan; 31(1):183-8. PubMed ID: 24247637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells.
    Liu KS; Liu H; Qi JH; Liu QY; Liu Z; Xia M; Xing GW; Wang SX; Wang YF
    Cancer Lett; 2012 May; 318(2):180-8. PubMed ID: 22182451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative inhibitory effect of sinomenine combined with 5-fluorouracil on esophageal carcinoma.
    Wang J; Yang ZR; Dong WG; Zhang JX; Guo XF; Song J; Qiu S
    World J Gastroenterol; 2013 Dec; 19(45):8292-300. PubMed ID: 24363520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Carotene synergistically enhances the anti-tumor effect of 5-fluorouracil on esophageal squamous cell carcinoma in vivo and in vitro.
    Zhang Y; Zhu X; Huang T; Chen L; Liu Y; Li Q; Song J; Ma S; Zhang K; Yang B; Guan F
    Toxicol Lett; 2016 Nov; 261():49-58. PubMed ID: 27586268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models.
    Hou W; Qin X; Zhu X; Fei M; Liu P; Liu L; Moon H; Zhang P; Greshock J; Bachman KE; Ye BC; Wang H; Zang CY
    Oncol Rep; 2013 Aug; 30(2):707-14. PubMed ID: 23708506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hsp90 inhibitor SNX-2112 induces apoptosis of human hepatocellular carcinoma cells: the role of ER stress.
    Wang X; Wang S; Liu Y; Ding W; Zheng K; Xiang Y; Liu K; Wang D; Zeng Y; Xia M; Yang D; Wang Y
    Biochem Biophys Res Commun; 2014 Mar; 446(1):160-6. PubMed ID: 24582562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
    Sivanantham B; Sethuraman S; Krishnan UM
    ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
    Tian F; Zhang C; Tian W; Jiang Y; Zhang X
    Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.